Main > ONCOLOGY (**) > Lymphoma>HL>Classical> *** > Treatment > Co: USA. S. BrentuxiMAb Vedotin>

---

Co: USA. S. BrentuxiMAb Vedotin>'s subsections
(*) JP Approval Date: 2018. 09.21
(*) USA Approval Date: 2011. 08.19
>After Failure auto-HSCT or>
>for Inj.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2011. 10.25.
TradeMark
TradeMark Web-Site

Co: USA. S. BrentuxiMAb Vedotin>'s products
This section has no products